News | Radiation Therapy | October 06, 2016

New Data on Elekta's MR-Linac Presented at ASTRO 2016

Multiple presentations highlight clinical potential of MR-linac in a variety of cancers and demonstrate the need to address intra-session motion

October 6, 2016 — Elekta announced recently that its high-field magnetic resonance linear accelerator (MR-linac) was the focus of multiple presentations at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting, held Sept. 25 – 28 in Boston. Additional abstracts presented by members of Elekta’s MR-linac Consortium also highlighted the need for adaptation of radiation therapy to address moving tumors and nearby organs during treatment sessions. Naturally occurring physiological movements currently limit the ability to conform the treatment to the target and increase exposure of radiation to healthy tissues.

Elekta’s MR-linac will integrate an advanced linear accelerator and a 1.5 Tesla magnetic resonance imaging (MRI) system. Combined, these systems will allow for simultaneous radiation therapy delivery and high-field MR tumor monitoring.

A joint session of ASTRO and the European Society for Radiation Oncology (ESTRO) highlighted the potential for adaptive imaging in radiation therapy during a session titled “In Room Adaptive Imaging with a Focus on MRI.”  Elekta’s MR-linac was featured in two presentations during this session:

  • “Linac-based MR Device”; Christopher Schultz, M.D., FACR, professor in the Department of Radiation Oncology at Froedert and Medical College of Wisconsin. This presentation discussed strategies for integrating MR-linac into current RT protocols and provided an overview of the development plan that the Elekta MR-linac Consortium is undertaking in order to generate the clinical, physics and quality control data that will be essential for developing and realizing the full clinical potential of MR-linac technology.
  • “MRI Linac: Physics Perspective”; Bas Raaymakers, Ph.D., professor in the Department of Radiotherapy at University Medical Center Utrecht. This presentation highlighted the potential to leverage the power of MR-linac technology to move from pre-treatment planning to online plan adaptation and, ultimately, to real-time plan adaptation. Raaymakers also discussed the need for novel quality assurance procedures for MR-linac devices, patients and workflow.

Additional key findings related to the MR-linac Consortium’s development of MR-linac presented at the conference include:

  • Abdominal organ motion is complex and can occur despite motion management strategies. Abstract #3708: “Complex Abdominal Organ Motion Assessed from MRI”; Eenas Omari, Ph.D., postdoctoral fellow in the Department of Radiation Oncology at Medical College of Wisconsin;
  • Substantially improves targeting and lowers radiation dose to normal breast tissue in patients undergoing pre-operative partial breast irradiation. Abstract #3695: “Dosimetric Feasibility of Pre-operative Partial Breast Irradiation in Prone Position Using MR-linac” ; Phil Prior, Ph.D., medical physicist in the Department of Radiation Oncology at Medical College of Wisconsin;
  • Clinically acceptable treatment plans for patients with locally advanced non-small cell lung cancer can be created. Abstract #3150: “Dosimetric Implications for Radical Radiotherapy on the MR-linac (MRL) in Locally Advanced Non-small Cell Lung Cancer (LA NSCLC)”; Hannah Bainbridge, M.D., clinical fellow lung team, The Institute of Cancer Research, Sutton, United Kingdom, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom;
  • Online adaptive replanning is feasible for prostate cancer radiation therapy. Abstract #3639: “A Hybrid Adaptive Replanning Approach for Prostate SBRT”; Ozgur Ates, Ph.D., postdoctoral fellow in the Department of Radiation Oncology at Medical College of Wisconsin; and
  • An automated quality assurance (QA) tool can quickly identify contour errors from auto-segmentation and may have utility in online adaptive replanning. Abstract #3638 “Implementation of a Machine-learning Based Automatic Contour QA Tool for Online Adaptive Radiotherapy of Prostate Cancer” ; Jing Qiao Zhang, Ph.D., postdoctoral fellow in the Department of Radiation Oncology at Medical College of Wisconsin.

 

Several additional presentations described the potential for MR-linac and adaptive therapy to enable dose painting — the precise delivery of varying doses of radiation to specific regions within a tumor in order to account for differences in cell type, location and density from one part of the tumor to another.

Elekta’s MR-linac is a work in progress and not available for sale or distribution.

For more information: www.elekta.com

Related Content

RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

News | Quality Assurance (QA) | July 08, 2019
At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will...
Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones
News | Radiation Therapy | July 05, 2019
Aktina Medical announced that Elekta Instrument AB, based in Sweden, will offer and distribute the Aktina line of...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...